echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Study of Nervous System > Stroke: Coagulation and inflammation biomarkers in patients with COVID-19-related ischemic stroke

    Stroke: Coagulation and inflammation biomarkers in patients with COVID-19-related ischemic stroke

    • Last Update: 2021-09-11
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Recently, the heart blood vessels published a research article on the disease areas authoritative journal Stroke, researchers have attempted to clear the inflammation and coagulation biomarkers whether 2019 will help coronavirus disease ( COVID-19 ) associated with ischemic stroke to determine It is a new subtype of acute ischemic stroke (AIS)


    Heart blood vessels COVID-19 Stroke

    Researchers performed machine learning cluster analysis on common biomarkers of ischemic stroke patients admitted to the hospital due to severe acute respiratory syndrome coronavirus 2 infection to determine whether they are related to AIS


    Infect

    Based on the levels of C-reactive protein, D-dimer, lactate dehydrogenase, white blood cell count and partial thromboplastin time, cluster analysis combined 2908 unique patients into 4 unique biomarker phenotypes


    D-dimer is the only biomarker independently related to the prevalence of AIS.


    It can be seen that the COVID-19-related ischemic stroke may be related to the severity of the COVID-19 disease and the coagulation disorder with elevated D-dimer


    The COVID-19-related ischemic stroke may be related to the severity of the COVID-19 disease and the coagulation disorder with elevated D-dimer


    Original source:

    Charles Esenwa.


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.